Log In
Print this Print this

Recombinant anti EGFR mAb

  Manage Alerts
Collapse Summary General Information
Company Sinocelltech Ltd.
DescriptionRecombinant human anti EGFR mAb
Molecular Target Epidermal growth factor receptor (EGFR)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase I
Standard IndicationColorectal cancer
Indication DetailsTreat metastatic colorectal cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today